Li‐Tzy Wu

11.4k total citations · 1 hit paper
215 papers, 8.3k citations indexed

About

Li‐Tzy Wu is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Li‐Tzy Wu has authored 215 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Epidemiology, 83 papers in Public Health, Environmental and Occupational Health and 51 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Li‐Tzy Wu's work include Substance Abuse Treatment and Outcomes (112 papers), Opioid Use Disorder Treatment (69 papers) and Prenatal Substance Exposure Effects (48 papers). Li‐Tzy Wu is often cited by papers focused on Substance Abuse Treatment and Outcomes (112 papers), Opioid Use Disorder Treatment (69 papers) and Prenatal Substance Exposure Effects (48 papers). Li‐Tzy Wu collaborates with scholars based in United States, China and Japan. Li‐Tzy Wu's co-authors include Dan G. Blazer, Daniel J. Pilowsky, Shawna L. Carroll Chapman, He Zhu, William E. Schlenger, Marvin S. Swartz, James C. Anthony, Paolo Mannelli, William S. John and Ashwin A. Patkar and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of Geophysical Research Atmospheres.

In The Last Decade

Li‐Tzy Wu

205 papers receiving 8.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment utilization among persons with opioid use disorder in the United States

2016 274 citations Li‐Tzy Wu, Marvin S. Swartz et al. Drug and Alcohol Dependence profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Li‐Tzy Wu	3.7k	2.5k	1.9k	1.7k	1.3k	215	8.3k
Robert Ali	4.4k 1.2×	3.5k 1.4×	1.0k 0.6×	1.2k 0.7×	1.1k 0.9×	183	8.6k
John Marsden	6.4k 1.7×	3.8k 1.5×	2.0k 1.0×	2.5k 1.5×	1.3k 1.0×	181	11.0k
Sílvia S. Martins	4.2k 1.1×	3.3k 1.3×	3.1k 1.7×	2.4k 1.4×	2.3k 1.8×	375	11.4k
Beth Han	1.8k 0.5×	2.4k 1.0×	2.0k 1.1×	1.7k 1.0×	1.3k 1.0×	104	7.7k
Richard Saitz	5.7k 1.5×	2.5k 1.0×	1.5k 0.8×	3.6k 2.1×	848 0.7×	274	10.4k
Shelly F. Greenfield	3.0k 0.8×	1.6k 0.7×	1.9k 1.0×	1.5k 0.9×	1.2k 0.9×	168	6.8k
Amelia M. Arria	2.7k 0.7×	3.0k 1.2×	2.8k 1.5×	1.9k 1.1×	3.2k 2.4×	208	10.6k
R. Kathryn McHugh	2.3k 0.6×	1.9k 0.7×	3.2k 1.7×	1.4k 0.8×	899 0.7×	173	8.7k
Steven Shoptaw	6.7k 1.8×	1.9k 0.8×	1.8k 1.0×	3.0k 1.7×	735 0.6×	432	13.4k
Mark J. Edlund	2.0k 0.5×	3.5k 1.4×	2.4k 1.3×	1.7k 1.0×	977 0.8×	101	9.0k

Countries citing papers authored by Li‐Tzy Wu

Since Specialization

Citations

This map shows the geographic impact of Li‐Tzy Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Tzy Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Tzy Wu more than expected).

Fields of papers citing papers by Li‐Tzy Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Tzy Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Tzy Wu. The network helps show where Li‐Tzy Wu may publish in the future.

Co-authorship network of co-authors of Li‐Tzy Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Tzy Wu. A scholar is included among the top collaborators of Li‐Tzy Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Tzy Wu. Li‐Tzy Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Li‐Tzy, et al.. (2025). Comparison of serious adverse effects of methylphenidate, atomoxetine and amphetamine in the treatment of ADHD: an adverse event analysis based on the FAERS database. BMC Pharmacology and Toxicology. 26(1). 38–38. 2 indexed citations

Figgatt, Mary, David L. Rosen, Vivian H. Chu, Li‐Tzy Wu, & Asher J Schranz. (2024). Long-term Risk of Serious Infections and Mortality Among Patients Surviving Drug Use–Associated Infective Endocarditis. Clinical Infectious Diseases. 79(1). 56–59. 2 indexed citations

Rush, A. John, Robert E. Gore‐Langton, Gavin Bart, et al.. (2024). Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus. Addiction Science & Clinical Practice. 19(1). 14–14.

Schranz, Asher J, Mary Figgatt, Vivian H. Chu, Li‐Tzy Wu, & David L. Rosen. (2024). Long-Term Mortality After Drug Use-Associated Endocarditis is High and Differs by Race and Sex: Results of a Statewide Study. Drug and Alcohol Dependence. 260. 110566–110566. 1 indexed citations

Han, Benjamin H., Joseph J. Palamar, Alison Moore, et al.. (2024). Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool in Screening Older Adults for Unhealthy Substance Use. Journal of Addiction Medicine. 19(1). 109–111. 1 indexed citations

Jarrett, Jennie B., Jeffrey Bratberg, Anne Burns, et al.. (2023). Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy. Substance Abuse. 44(4). 264–276. 8 indexed citations

Ranapurwala, Shabbar I., Ishrat Z Alam, Brian W. Pence, et al.. (2022). Development and validation of an electronic health records‐based opioid use disorder algorithm by expert clinical adjudication among patients with prescribed opioids. Pharmacoepidemiology and Drug Safety. 32(5). 577–585. 9 indexed citations

Subica, Andrew M., Nia Aitaoto, Brittany N. Morey, et al.. (2022). Assessing the Impact of COVID-19 on the Health of Native Hawaiian/Pacific Islander People in the United States, 2021. Public Health Reports. 138(1). 164–173. 7 indexed citations

Maxwell, Jane Carlisle, et al.. (2020). Prevalence and Health Characteristics of Prescription Opioid Use, Misuse, and Use Disorders Among U.S. Adolescents. Journal of Adolescent Health. 66(5). 536–544. 27 indexed citations

10.

Subica, Andrew M., Erick G. Guerrero, Li‐Tzy Wu, et al.. (2020). Electronic Cigarette Use and Associated Risk Factors in U.S.-Dwelling Pacific Islander Young Adults. Substance Use & Misuse. 55(10). 1702–1708. 13 indexed citations

11.

Subica, Andrew M., Erick G. Guerrero, Nia Aitaoto, et al.. (2020). Hazardous drinking, alcohol use disorders, and need for treatment among Pacific Islander young adults.. American Journal of Orthopsychiatry. 90(5). 557–566. 10 indexed citations

12.

Schranz, Asher J, Li‐Tzy Wu, David A. Wohl, & David L. Rosen. (2019). Abstract 11954: Readmission After Discharge Against Medical Advice for Persons With Opioid-Associated Infective Endocarditis. Circulation. 1 indexed citations

13.

Schranz, Asher J, Aaron T. Fleischauer, Vivian H. Chu, Li‐Tzy Wu, & David L. Rosen. (2018). Trends in Drug Use–Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017. Annals of Internal Medicine. 8 indexed citations

14.

Subica, Andrew M. & Li‐Tzy Wu. (2018). Substance Use and Suicide in Pacific Islander, American Indian, and Multiracial Youth. American Journal of Preventive Medicine. 54(6). 795–805. 82 indexed citations

15.

John, William S. & Li‐Tzy Wu. (2017). Trends and correlates of cocaine use and cocaine use disorder in the United States from 2011 to 2015. Drug and Alcohol Dependence. 180. 376–384. 102 indexed citations

16.

Wu, Li‐Tzy, et al.. (2017). Differences in behavioral health disorders and unmet treatment needs between medical marijuana users and recreational marijuana users: Results from a national adult sample. Drug and Alcohol Dependence. 180. 311–318. 8 indexed citations

17.

Li, Linlin, Adriana Pérez, Li‐Tzy Wu, et al.. (2016). Cardiometabolic Risk Factors among Severely Obese Children and Adolescents in the United States, 1999–2012. Childhood Obesity. 12(1). 12–19. 48 indexed citations

18.

Wu, Li‐Tzy, Marvin S. Swartz, Bruce M. Burchett, et al.. (2012). Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults. General Hospital Psychiatry. 35(1). 74–82. 8 indexed citations

19.

Wu, Li‐Tzy, Christopher L. Ringwalt, Paolo Mannelli, & Ashwin A. Patkar. (2008). Prescription Pain Reliever Abuse and Dependence Among Adolescents: A Nationally Representative Study. Journal of the American Academy of Child & Adolescent Psychiatry. 47(9). 1020–1029. 54 indexed citations

20.

Wu, Li‐Tzy, Christopher L. Ringwalt, & Charles E. Williams. (2003). Use of Substance Abuse Treatment Services by Persons With Mental Health and Substance Use Problems. Psychiatric Services. 54(3). 363–369. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact